Nanoscavenger provides long-term prophylactic protection against nerve agents in rodents

Area of Science:

• Toxicology
• Nanotechnology
• Pharmacology

Background:

• Nerve agents, a class of organophosphorus compounds (OPs), cause acute neurotoxicity, making victim rescue challenging.
• Existing prophylactic nerve agent bioscavengers face limitations including low efficiency, poor pharmacokinetics, and immunological issues.

Purpose of the Study:

• To develop and test a nanoparticle-based nerve agent bioscavenger (nanoscavenger) for effective protection against OP intoxication.
• To evaluate the nanoscavenger's pharmacokinetic profile, immunogenicity, and therapeutic efficacy in animal models.

Main Methods:

• Development of a nanoparticle-based catalytic bioscavenger designed to break down toxic OP compounds.
• Pharmacokinetic and immunological assessments in a rat model of OP intoxication.
• In vivo efficacy studies in rodent and guinea pig models following OP exposure, including sarin.

Main Results:

• The nanoscavenger demonstrated a favorable pharmacokinetic profile and negligible immune response in rats.
• Administration of the nanoscavenger before or after OP exposure showed protective and therapeutic effects in animal models.
• A single prophylactic dose prevented lethality in guinea pigs after multiple sarin exposures over seven days.

Conclusions:

• Nanoparticle-based nerve agent bioscavengers offer a promising strategy for preventing OP intoxication.
• Prophylactic administration of this nanoscavenger may be effective in mitigating the toxic effects of OP exposure in humans.